At 2 years, Black and white patients who received Lucentis for the treatment of diabetic macular edema achieved similar ...

The long-acting monoclonal antibody nirsevimab (Beyfortus) protects children younger than 2 years from respiratory syncytial ...

Recently, minimally invasive surgery has been attempted in various diseases and is becoming a new standard, and a study ...

Open-label prophylaxis data supporting the long-term safety profile and sustained benefits of deucrictibant, as well as clinical validation data ...

Adults with vs. without atopic disease had higher risks for difficulties after breast reconstruction and bone grafting, according to data presented at the American College of Allergy, Asthma & ...

Harry Kane has led the line for a decade but with no obvious alternative among other strikers could Madrid's midfielder be a ...

Medicare Advantage plans that place greater restrictions on home health agency care delivery may have more adverse patient outcomes than plans that provide episodic payments.

It's playoff time in the NWSL, but can anyone stop the Kansas City Current from cruising to the title? Here's how every team could win it all -- and the one thing that might hold each of them back.

In nearly every set of Tuesday night’s D1 regional semifinal, Birmingham Groves built an early lead of at least four points ...

A RECENT Greek study presented at EASD 2025 has suggested that semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, provides strong protection against diabetic retinopathy, the leading ...

THIS AUTUMN, Paris, France, hosted the 34ᵗʰ annual European Academy of Dermatology and Venereology (EADV) Congress.